You are here

  • Home
  • Archive
  • Volume 3, Issue 1
  • Hyperbilirubinaemia in HIV–HCV co-infected patients on antiretroviral therapy: drug effect or liver disease severity?

Article metrics

Article menu

Download PDFPDF

XML
Hepatology
Hyperbilirubinaemia in HIV–HCV co-infected patients on antiretroviral therapy: drug effect or liver disease severity?

 

Online download statistics by month:

Online download statistics by month: June 2017 to September 2024

AbstractFullPdf
Jun 2017110
Jul 201728287
Aug 201719199
Sep 201712124
Oct 201713137
Nov 201714144
Dec 201726263
Jan 2018262610
Feb 201823236
Mar 201835379
Apr 201829297
May 201852529
Jun 201826278
Jul 201840409
Aug 2018272711
Sep 201818184
Oct 2018334
Nov 201810106
Dec 201810107
Jan 2019667
Feb 201915155
Mar 2019778
Apr 2019334
May 20198713
Jun 20197711
Jul 20198815
Aug 2019778
Sep 2019339
Oct 2019202114
Nov 2019445
Dec 201910910
Jan 2020774
Feb 2020151413
Mar 2020323211
Apr 2020121210
May 2020997
Jun 2020777
Jul 202013135
Aug 2020567
Sep 2020171713
Oct 202011117
Nov 2020453
Dec 2020685
Jan 2021673
Feb 2021775
Mar 20211196
Apr 2021223
May 2021115
Jun 2021551
Jul 2021555
Aug 2021223
Sep 20214410
Oct 20218815
Nov 20218811
Dec 20211292
Jan 20229102
Feb 2022554
Mar 202211114
Apr 202235351
May 2022876
Jun 202215157
Jul 2022662
Aug 202211112
Sep 2022666
Oct 20220013
Nov 2022551
Dec 2022662
Jan 202390904
Feb 2023992
Mar 202312122
Apr 2023443
May 202351526
Jun 2023442
Jul 2023443
Aug 2023543
Sep 2023224
Oct 2023441
Nov 2023772
Dec 202311111
Jan 2024660
Feb 2024332
Mar 202411116
Apr 202417178
May 2024660
Jun 202420166
Jul 202417145
Aug 2024773
Sep 202412104
Total11381130511